Company intelligence / Profile preview

PrimeraDx

Mansfield, Massachusetts, United States

Ownership: Private
Employees: ~125
Development stage: Other

Overview

PrimeraDx is a molecular diagnostics company that developed the ICEPlex system, a bench-top instrument combining PCR with capillary electrophoresis for highly multiplexed, quantitative molecular diagnosis. The company focused on infectious disease management, with plans to expand into oncology for diagnostics, prognostics, staging, and therapeutic monitoring. PrimeraDx partnered with Quest Diagnostics to co-develop companion diagnostics for targeted therapeutics, primarily in oncology.

Therapeutic areas: OncologyInfectious DiseasesRare Diseases
Modalities: Nucleic acid testMolecular diagnostic device
Industry: Molecular Diagnostics

Partnerships

Quest Diagnostics

Beyond the preview

Go deeper on PrimeraDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrimeraDx.

Explore the full profile